世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および中国の生物学的API医薬品製造市場の洞察、2027年までの予測


Global and China Biological API Drug Manufacturing Market Insights, Forecast to 2027

ヒト、動物、微生物、遺伝子工学、またはそのソースを変更し、発酵、細菌培養、バイオテクノロジー、その後の精製プロセスを経て製造されるAPIです。 市場分析とインサイト世界および中国の生物学的API医薬品... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年11月19日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ヒト、動物、微生物、遺伝子工学、またはそのソースを変更し、発酵、細菌培養、バイオテクノロジー、その後の精製プロセスを経て製造されるAPIです。

市場分析とインサイト世界および中国の生物学的API医薬品製造市場
当レポートでは、世界および中国の生物学的API医薬品製造市場に焦点を当てています。
2020年の世界のBiological API Drug Manufacturing市場規模はXX百万米ドルで、2021年から2027年の間にXX%のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。中国では、Biological API Drug Manufacturingの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。

世界の生物学的製剤(API)製造の範囲と市場規模
生物学的API医薬品製造市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のBiological API Drug Manufacturing市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
中国市場については、2016年から2027年の期間で、プレイヤー別、タイプ別、アプリケーション別の生物学的API医薬品製造市場規模に焦点を当てています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
院内製造
委託製造
原薬受託製造は、世界の生物学的原薬製造市場を支配している。

用途別セグメント
モノクローナル抗体(mAb)治療薬
ワクチン
インスリン治療薬
インターフェロン治療薬
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
ロンザ
ベーリンガーインゲルハイムバイオエクセレンス
セルトリオン
DSM
サムスンバイオロジックス
富士フイルム ダイオシンス・バイオテクノロジーズ
サイトバンス・バイオロジクス(Cytovance Biologics
AbbVie
バクスター
CEPiA サノフィ
GSK
ファイザー センターワン
サンドラッグ
ベッター
無錫バイオロジクス


ページTOPに戻る


目次

1 Study Coverage
1.1 Biological API Drug Manufacturing Product Introduction
1.2 Market by Type
1.2.1 Global Biological API Drug Manufacturing Market Size Growth Rate by Type
1.2.2 In-House manufacturing
1.2.3 Contract manufacturing
1.3 Market by Application
1.3.1 Global Biological API Drug Manufacturing Market Size Growth Rate by Application
1.3.2 Monoclonal Antibody (mAb) Therapies
1.3.3 Vaccines
1.3.4 Insulin Therapies
1.3.5 Interferon Therapies
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Biological API Drug Manufacturing Market Size, Estimates and Forecasts
2.1.1 Global Biological API Drug Manufacturing Revenue 2016-2027
2.1.2 Global Biological API Drug Manufacturing Sales 2016-2027
2.2 Global Biological API Drug Manufacturing, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Biological API Drug Manufacturing Historical Market Size by Region (2016-2021)
2.3.1 Global Biological API Drug Manufacturing Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Biological API Drug Manufacturing Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Biological API Drug Manufacturing Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Biological API Drug Manufacturing Sales Forecast by Region (2022-2027)
2.4.2 Global Biological API Drug Manufacturing Revenue Forecast by Region (2022-2027)

3 Global Biological API Drug Manufacturing Competitor Landscape by Players
3.1 Global Top Biological API Drug Manufacturing Manufacturers by Sales
3.1.1 Global Biological API Drug Manufacturing Sales by Manufacturer (2016-2021)
3.1.2 Global Biological API Drug Manufacturing Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Biological API Drug Manufacturing Manufacturers by Revenue
3.2.1 Key Biological API Drug Manufacturing Manufacturers Covered: Ranking by Revenue
3.2.2 Global Biological API Drug Manufacturing Revenue by Manufacturers (2016-2021)
3.2.3 Global Biological API Drug Manufacturing Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Biological API Drug Manufacturing Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Biological API Drug Manufacturing Revenue in 2020
3.2.6 Global Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biological API Drug Manufacturing Price by Manufacturers
3.4 Global Biological API Drug Manufacturing Manufacturing Base Distribution, Product Types
3.4.1 Biological API Drug Manufacturing Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biological API Drug Manufacturing Product Type
3.4.3 Date of International Manufacturers Enter into Biological API Drug Manufacturing Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Biological API Drug Manufacturing Market Size by Type (2016-2021)
4.1.1 Global Biological API Drug Manufacturing Sales by Type (2016-2021)
4.1.2 Global Biological API Drug Manufacturing Revenue by Type (2016-2021)
4.1.3 Biological API Drug Manufacturing Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Biological API Drug Manufacturing Market Size Forecast by Type (2022-2027)
4.2.1 Global Biological API Drug Manufacturing Sales Forecast by Type (2022-2027)
4.2.2 Global Biological API Drug Manufacturing Revenue Forecast by Type (2022-2027)
4.2.3 Biological API Drug Manufacturing Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Biological API Drug Manufacturing Market Size by Application (2016-2021)
5.1.1 Global Biological API Drug Manufacturing Sales by Application (2016-2021)
5.1.2 Global Biological API Drug Manufacturing Revenue by Application (2016-2021)
5.1.3 Biological API Drug Manufacturing Price by Application (2016-2021)
5.2 Biological API Drug Manufacturing Market Size Forecast by Application (2022-2027)
5.2.1 Global Biological API Drug Manufacturing Sales Forecast by Application (2022-2027)
5.2.2 Global Biological API Drug Manufacturing Revenue Forecast by Application (2022-2027)
5.2.3 Global Biological API Drug Manufacturing Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
6.1.1 China Biological API Drug Manufacturing Sales YoY Growth 2016-2027
6.1.2 China Biological API Drug Manufacturing Revenue YoY Growth 2016-2027
6.1.3 China Biological API Drug Manufacturing Market Share in Global Market 2016-2027
6.2 China Biological API Drug Manufacturing Market Size by Players (International and Local Players)
6.2.1 China Top Biological API Drug Manufacturing Players by Sales (2016-2021)
6.2.2 China Top Biological API Drug Manufacturing Players by Revenue (2016-2021)
6.3 China Biological API Drug Manufacturing Historic Market Review by Type (2016-2021)
6.3.1 China Biological API Drug Manufacturing Sales Market Share by Type (2016-2021)
6.3.2 China Biological API Drug Manufacturing Revenue Market Share by Type (2016-2021)
6.3.3 China Biological API Drug Manufacturing Price by Type (2016-2021)
6.4 China Biological API Drug Manufacturing Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Biological API Drug Manufacturing Sales Forecast by Type (2022-2027)
6.4.2 China Biological API Drug Manufacturing Revenue Forecast by Type (2022-2027)
6.4.3 China Biological API Drug Manufacturing Price Forecast by Type (2022-2027)
6.5 China Biological API Drug Manufacturing Historic Market Review by Application (2016-2021)
6.5.1 China Biological API Drug Manufacturing Sales Market Share by Application (2016-2021)
6.5.2 China Biological API Drug Manufacturing Revenue Market Share by Application (2016-2021)
6.5.3 China Biological API Drug Manufacturing Price by Application (2016-2021)
6.6 China Biological API Drug Manufacturing Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Biological API Drug Manufacturing Sales Forecast by Application (2022-2027)
6.6.2 China Biological API Drug Manufacturing Revenue Forecast by Application (2022-2027)
6.6.3 China Biological API Drug Manufacturing Price Forecast by Application (2022-2027)

7 North America
7.1 North America Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
7.2 North America Biological API Drug Manufacturing Market Facts & Figures by Country
7.2.1 North America Biological API Drug Manufacturing Sales by Country (2016-2021)
7.2.2 North America Biological API Drug Manufacturing Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
8.2 Asia Pacific Biological API Drug Manufacturing Market Facts & Figures by Region
8.2.1 Asia Pacific Biological API Drug Manufacturing Sales by Region (2016-2021)
8.2.2 Asia Pacific Biological API Drug Manufacturing Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
9.2 Europe Biological API Drug Manufacturing Market Facts & Figures by Country
9.2.1 Europe Biological API Drug Manufacturing Sales by Country (2016-2021)
9.2.2 Europe Biological API Drug Manufacturing Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
10.2 Latin America Biological API Drug Manufacturing Market Facts & Figures by Country
10.2.1 Latin America Biological API Drug Manufacturing Sales by Country (2016-2021)
10.2.2 Latin America Biological API Drug Manufacturing Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Biological API Drug Manufacturing Market Facts & Figures by Country
11.2.1 Middle East and Africa Biological API Drug Manufacturing Sales by Country (2016-2021)
11.2.2 Middle East and Africa Biological API Drug Manufacturing Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Lonza
12.1.1 Lonza Corporation Information
12.1.2 Lonza Description and Business Overview
12.1.3 Lonza Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Lonza Biological API Drug Manufacturing Products Offered
12.1.5 Lonza Recent Development
12.2 Boehringer Ingelheim BioXcellence
12.2.1 Boehringer Ingelheim BioXcellence Corporation Information
12.2.2 Boehringer Ingelheim BioXcellence Description and Business Overview
12.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Products Offered
12.2.5 Boehringer Ingelheim BioXcellence Recent Development
12.3 Celltrion
12.3.1 Celltrion Corporation Information
12.3.2 Celltrion Description and Business Overview
12.3.3 Celltrion Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Celltrion Biological API Drug Manufacturing Products Offered
12.3.5 Celltrion Recent Development
12.4 DSM
12.4.1 DSM Corporation Information
12.4.2 DSM Description and Business Overview
12.4.3 DSM Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.4.4 DSM Biological API Drug Manufacturing Products Offered
12.4.5 DSM Recent Development
12.5 Samsung BioLogics
12.5.1 Samsung BioLogics Corporation Information
12.5.2 Samsung BioLogics Description and Business Overview
12.5.3 Samsung BioLogics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Samsung BioLogics Biological API Drug Manufacturing Products Offered
12.5.5 Samsung BioLogics Recent Development
12.6 Fujifilm Diosynth Biotechnologies
12.6.1 Fujifilm Diosynth Biotechnologies Corporation Information
12.6.2 Fujifilm Diosynth Biotechnologies Description and Business Overview
12.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Products Offered
12.6.5 Fujifilm Diosynth Biotechnologies Recent Development
12.7 Cytovance Biologics
12.7.1 Cytovance Biologics Corporation Information
12.7.2 Cytovance Biologics Description and Business Overview
12.7.3 Cytovance Biologics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cytovance Biologics Biological API Drug Manufacturing Products Offered
12.7.5 Cytovance Biologics Recent Development
12.8 AbbVie
12.8.1 AbbVie Corporation Information
12.8.2 AbbVie Description and Business Overview
12.8.3 AbbVie Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.8.4 AbbVie Biological API Drug Manufacturing Products Offered
12.8.5 AbbVie Recent Development
12.9 Baxter
12.9.1 Baxter Corporation Information
12.9.2 Baxter Description and Business Overview
12.9.3 Baxter Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Baxter Biological API Drug Manufacturing Products Offered
12.9.5 Baxter Recent Development
12.10 CEPiA Sanofi
12.10.1 CEPiA Sanofi Corporation Information
12.10.2 CEPiA Sanofi Description and Business Overview
12.10.3 CEPiA Sanofi Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CEPiA Sanofi Biological API Drug Manufacturing Products Offered
12.10.5 CEPiA Sanofi Recent Development
12.11 Lonza
12.11.1 Lonza Corporation Information
12.11.2 Lonza Description and Business Overview
12.11.3 Lonza Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lonza Biological API Drug Manufacturing Products Offered
12.11.5 Lonza Recent Development
12.12 Pfizer CentreOne
12.12.1 Pfizer CentreOne Corporation Information
12.12.2 Pfizer CentreOne Description and Business Overview
12.12.3 Pfizer CentreOne Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Pfizer CentreOne Products Offered
12.12.5 Pfizer CentreOne Recent Development
12.13 Sandoz
12.13.1 Sandoz Corporation Information
12.13.2 Sandoz Description and Business Overview
12.13.3 Sandoz Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sandoz Products Offered
12.13.5 Sandoz Recent Development
12.14 Vetter
12.14.1 Vetter Corporation Information
12.14.2 Vetter Description and Business Overview
12.14.3 Vetter Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Vetter Products Offered
12.14.5 Vetter Recent Development
12.15 Wuxi Biologics
12.15.1 Wuxi Biologics Corporation Information
12.15.2 Wuxi Biologics Description and Business Overview
12.15.3 Wuxi Biologics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Wuxi Biologics Products Offered
12.15.5 Wuxi Biologics Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Biological API Drug Manufacturing Industry Trends
13.2 Biological API Drug Manufacturing Market Drivers
13.3 Biological API Drug Manufacturing Market Challenges
13.4 Biological API Drug Manufacturing Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biological API Drug Manufacturing Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

It is an API produced by human, animal, microbial, genetic engineering or changing its source and through fermentation, bacterial culture, biotechnology and subsequent purification processes.

Market Analysis and Insights: Global and China Biological API Drug Manufacturing Market
This report focuses on global and China Biological API Drug Manufacturing market.
In 2020, the global Biological API Drug Manufacturing market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Biological API Drug Manufacturing market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Biological API Drug Manufacturing Scope and Market Size
Biological API Drug Manufacturing market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Biological API Drug Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Biological API Drug Manufacturing market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
In-House manufacturing
Contract manufacturing
API contract manufacturing dominates the global biological API drug manufacturing market.

Segment by Application
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Biological API Drug Manufacturing Product Introduction
1.2 Market by Type
1.2.1 Global Biological API Drug Manufacturing Market Size Growth Rate by Type
1.2.2 In-House manufacturing
1.2.3 Contract manufacturing
1.3 Market by Application
1.3.1 Global Biological API Drug Manufacturing Market Size Growth Rate by Application
1.3.2 Monoclonal Antibody (mAb) Therapies
1.3.3 Vaccines
1.3.4 Insulin Therapies
1.3.5 Interferon Therapies
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Biological API Drug Manufacturing Market Size, Estimates and Forecasts
2.1.1 Global Biological API Drug Manufacturing Revenue 2016-2027
2.1.2 Global Biological API Drug Manufacturing Sales 2016-2027
2.2 Global Biological API Drug Manufacturing, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Biological API Drug Manufacturing Historical Market Size by Region (2016-2021)
2.3.1 Global Biological API Drug Manufacturing Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Biological API Drug Manufacturing Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Biological API Drug Manufacturing Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Biological API Drug Manufacturing Sales Forecast by Region (2022-2027)
2.4.2 Global Biological API Drug Manufacturing Revenue Forecast by Region (2022-2027)

3 Global Biological API Drug Manufacturing Competitor Landscape by Players
3.1 Global Top Biological API Drug Manufacturing Manufacturers by Sales
3.1.1 Global Biological API Drug Manufacturing Sales by Manufacturer (2016-2021)
3.1.2 Global Biological API Drug Manufacturing Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Biological API Drug Manufacturing Manufacturers by Revenue
3.2.1 Key Biological API Drug Manufacturing Manufacturers Covered: Ranking by Revenue
3.2.2 Global Biological API Drug Manufacturing Revenue by Manufacturers (2016-2021)
3.2.3 Global Biological API Drug Manufacturing Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Biological API Drug Manufacturing Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Biological API Drug Manufacturing Revenue in 2020
3.2.6 Global Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Biological API Drug Manufacturing Price by Manufacturers
3.4 Global Biological API Drug Manufacturing Manufacturing Base Distribution, Product Types
3.4.1 Biological API Drug Manufacturing Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biological API Drug Manufacturing Product Type
3.4.3 Date of International Manufacturers Enter into Biological API Drug Manufacturing Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Biological API Drug Manufacturing Market Size by Type (2016-2021)
4.1.1 Global Biological API Drug Manufacturing Sales by Type (2016-2021)
4.1.2 Global Biological API Drug Manufacturing Revenue by Type (2016-2021)
4.1.3 Biological API Drug Manufacturing Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Biological API Drug Manufacturing Market Size Forecast by Type (2022-2027)
4.2.1 Global Biological API Drug Manufacturing Sales Forecast by Type (2022-2027)
4.2.2 Global Biological API Drug Manufacturing Revenue Forecast by Type (2022-2027)
4.2.3 Biological API Drug Manufacturing Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Biological API Drug Manufacturing Market Size by Application (2016-2021)
5.1.1 Global Biological API Drug Manufacturing Sales by Application (2016-2021)
5.1.2 Global Biological API Drug Manufacturing Revenue by Application (2016-2021)
5.1.3 Biological API Drug Manufacturing Price by Application (2016-2021)
5.2 Biological API Drug Manufacturing Market Size Forecast by Application (2022-2027)
5.2.1 Global Biological API Drug Manufacturing Sales Forecast by Application (2022-2027)
5.2.2 Global Biological API Drug Manufacturing Revenue Forecast by Application (2022-2027)
5.2.3 Global Biological API Drug Manufacturing Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
6.1.1 China Biological API Drug Manufacturing Sales YoY Growth 2016-2027
6.1.2 China Biological API Drug Manufacturing Revenue YoY Growth 2016-2027
6.1.3 China Biological API Drug Manufacturing Market Share in Global Market 2016-2027
6.2 China Biological API Drug Manufacturing Market Size by Players (International and Local Players)
6.2.1 China Top Biological API Drug Manufacturing Players by Sales (2016-2021)
6.2.2 China Top Biological API Drug Manufacturing Players by Revenue (2016-2021)
6.3 China Biological API Drug Manufacturing Historic Market Review by Type (2016-2021)
6.3.1 China Biological API Drug Manufacturing Sales Market Share by Type (2016-2021)
6.3.2 China Biological API Drug Manufacturing Revenue Market Share by Type (2016-2021)
6.3.3 China Biological API Drug Manufacturing Price by Type (2016-2021)
6.4 China Biological API Drug Manufacturing Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Biological API Drug Manufacturing Sales Forecast by Type (2022-2027)
6.4.2 China Biological API Drug Manufacturing Revenue Forecast by Type (2022-2027)
6.4.3 China Biological API Drug Manufacturing Price Forecast by Type (2022-2027)
6.5 China Biological API Drug Manufacturing Historic Market Review by Application (2016-2021)
6.5.1 China Biological API Drug Manufacturing Sales Market Share by Application (2016-2021)
6.5.2 China Biological API Drug Manufacturing Revenue Market Share by Application (2016-2021)
6.5.3 China Biological API Drug Manufacturing Price by Application (2016-2021)
6.6 China Biological API Drug Manufacturing Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Biological API Drug Manufacturing Sales Forecast by Application (2022-2027)
6.6.2 China Biological API Drug Manufacturing Revenue Forecast by Application (2022-2027)
6.6.3 China Biological API Drug Manufacturing Price Forecast by Application (2022-2027)

7 North America
7.1 North America Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
7.2 North America Biological API Drug Manufacturing Market Facts & Figures by Country
7.2.1 North America Biological API Drug Manufacturing Sales by Country (2016-2021)
7.2.2 North America Biological API Drug Manufacturing Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
8.2 Asia Pacific Biological API Drug Manufacturing Market Facts & Figures by Region
8.2.1 Asia Pacific Biological API Drug Manufacturing Sales by Region (2016-2021)
8.2.2 Asia Pacific Biological API Drug Manufacturing Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
9.2 Europe Biological API Drug Manufacturing Market Facts & Figures by Country
9.2.1 Europe Biological API Drug Manufacturing Sales by Country (2016-2021)
9.2.2 Europe Biological API Drug Manufacturing Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
10.2 Latin America Biological API Drug Manufacturing Market Facts & Figures by Country
10.2.1 Latin America Biological API Drug Manufacturing Sales by Country (2016-2021)
10.2.2 Latin America Biological API Drug Manufacturing Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Biological API Drug Manufacturing Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Biological API Drug Manufacturing Market Facts & Figures by Country
11.2.1 Middle East and Africa Biological API Drug Manufacturing Sales by Country (2016-2021)
11.2.2 Middle East and Africa Biological API Drug Manufacturing Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Lonza
12.1.1 Lonza Corporation Information
12.1.2 Lonza Description and Business Overview
12.1.3 Lonza Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Lonza Biological API Drug Manufacturing Products Offered
12.1.5 Lonza Recent Development
12.2 Boehringer Ingelheim BioXcellence
12.2.1 Boehringer Ingelheim BioXcellence Corporation Information
12.2.2 Boehringer Ingelheim BioXcellence Description and Business Overview
12.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Products Offered
12.2.5 Boehringer Ingelheim BioXcellence Recent Development
12.3 Celltrion
12.3.1 Celltrion Corporation Information
12.3.2 Celltrion Description and Business Overview
12.3.3 Celltrion Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Celltrion Biological API Drug Manufacturing Products Offered
12.3.5 Celltrion Recent Development
12.4 DSM
12.4.1 DSM Corporation Information
12.4.2 DSM Description and Business Overview
12.4.3 DSM Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.4.4 DSM Biological API Drug Manufacturing Products Offered
12.4.5 DSM Recent Development
12.5 Samsung BioLogics
12.5.1 Samsung BioLogics Corporation Information
12.5.2 Samsung BioLogics Description and Business Overview
12.5.3 Samsung BioLogics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Samsung BioLogics Biological API Drug Manufacturing Products Offered
12.5.5 Samsung BioLogics Recent Development
12.6 Fujifilm Diosynth Biotechnologies
12.6.1 Fujifilm Diosynth Biotechnologies Corporation Information
12.6.2 Fujifilm Diosynth Biotechnologies Description and Business Overview
12.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Products Offered
12.6.5 Fujifilm Diosynth Biotechnologies Recent Development
12.7 Cytovance Biologics
12.7.1 Cytovance Biologics Corporation Information
12.7.2 Cytovance Biologics Description and Business Overview
12.7.3 Cytovance Biologics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cytovance Biologics Biological API Drug Manufacturing Products Offered
12.7.5 Cytovance Biologics Recent Development
12.8 AbbVie
12.8.1 AbbVie Corporation Information
12.8.2 AbbVie Description and Business Overview
12.8.3 AbbVie Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.8.4 AbbVie Biological API Drug Manufacturing Products Offered
12.8.5 AbbVie Recent Development
12.9 Baxter
12.9.1 Baxter Corporation Information
12.9.2 Baxter Description and Business Overview
12.9.3 Baxter Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Baxter Biological API Drug Manufacturing Products Offered
12.9.5 Baxter Recent Development
12.10 CEPiA Sanofi
12.10.1 CEPiA Sanofi Corporation Information
12.10.2 CEPiA Sanofi Description and Business Overview
12.10.3 CEPiA Sanofi Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CEPiA Sanofi Biological API Drug Manufacturing Products Offered
12.10.5 CEPiA Sanofi Recent Development
12.11 Lonza
12.11.1 Lonza Corporation Information
12.11.2 Lonza Description and Business Overview
12.11.3 Lonza Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lonza Biological API Drug Manufacturing Products Offered
12.11.5 Lonza Recent Development
12.12 Pfizer CentreOne
12.12.1 Pfizer CentreOne Corporation Information
12.12.2 Pfizer CentreOne Description and Business Overview
12.12.3 Pfizer CentreOne Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Pfizer CentreOne Products Offered
12.12.5 Pfizer CentreOne Recent Development
12.13 Sandoz
12.13.1 Sandoz Corporation Information
12.13.2 Sandoz Description and Business Overview
12.13.3 Sandoz Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sandoz Products Offered
12.13.5 Sandoz Recent Development
12.14 Vetter
12.14.1 Vetter Corporation Information
12.14.2 Vetter Description and Business Overview
12.14.3 Vetter Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Vetter Products Offered
12.14.5 Vetter Recent Development
12.15 Wuxi Biologics
12.15.1 Wuxi Biologics Corporation Information
12.15.2 Wuxi Biologics Description and Business Overview
12.15.3 Wuxi Biologics Biological API Drug Manufacturing Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Wuxi Biologics Products Offered
12.15.5 Wuxi Biologics Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Biological API Drug Manufacturing Industry Trends
13.2 Biological API Drug Manufacturing Market Drivers
13.3 Biological API Drug Manufacturing Market Challenges
13.4 Biological API Drug Manufacturing Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biological API Drug Manufacturing Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(アプリケーションソフト)の最新刊レポート

本レポートと同じKEY WORD(drug)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る